Walden Biosciences is a biotechnology company relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease. We are developing breakthrough medicines targeted directly to the kidney and will be successful through our comprehensive knowledge and understanding of novel kidney-specific biological pathways and our team’s track record in drug discovery. Our goal is to transform the treatment of kidney disease by reversing its progression, enabling and inspiring patients to resume their normal lives.
Our culture is collaborative and entrepreneurial, and our team is dynamic and driven by data and innovation. We want to make the best decisions with the best available information, lead by example, and bring transformative medicines to patients in need.
Walden is based in the heart of Cambridge, MA between Harvard, Massachusetts Institute of Technology (MIT), and Massachusetts General Hospital.
Company Details
- Employees
- 21
- Founded
- -
- Address
- One Kendall Square,
- in****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- waldenbiosciences.com
- Keywords
- Representative jobs.
- HQ
- Cambridge, MA
Walden Biosciences Questions
Walden Biosciences's website is waldenbiosciences.com
Walden Biosciences's LinkedIn profile is https://www.linkedin.com/company/waldenbiosciences
Walden Biosciences has
21 employees.
View email and phone details for 21
employees at Walden Biosciences.
Walden Biosciences's industry is
Biotechnology Research
Walden Biosciences's top competitors are
Beacon Therapeutics,
Triana Biomedicines,
Accent Therapeutics, Inc.,
Tevard Biosciences,
Pretzel Therapeutics,
Manifold Bio,
Transition Bio, Inc.,
Kalvista Pharmaceuticals, Inc.,
Goldfinch Bio,
Parabilis Medicines.
Walden Biosciences's support email address is info@waldenbiosciences.com
Walden Biosciences's categories are Biotechnology Research
Walden Biosciences's founding year is 2020
